DUBLIN--(BUSINESS WIRE)--The "Nebulizers Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
The nebulizer market by revenue is expected to grow at a CAGR of over 7% during the period 2019-2025.
The global nebulizer market is one of the steady growing segments in the global medical devices market. It is expected to grow at a healthy pace during the forecast period. This surge can be attributable to the growing prevalence of asthma, chronic obstructive pulmonary disease (COPD) patients, cystic fibrosis, and the outbreak of the COVID-19 pandemic. The rising incidence of chronic respiratory diseases is increasing the demand for nebulizers at a significant rate over the past few years across the globe. According to the WHO, COPD is expected to emerge as the third leading cause of death across the world by 2025.
The rise in COVID-19 cases across the globe has increased the demand for nebulizers. The device's usage to treat the coronavirus affected patients is growing during the COVID-19 pandemic. According to the WHO, more than 180 countries are affected by COVID-19. Italy, Spain, the UK, the US, China, France, Spain, Iran, Germany, the Netherlands, and Belgium accounted for more than 75% of the cases. With 20% to 40% and 5% to 15% of COVID-19 patients requiring hospitalization and intensive/emergency care, the demand for medical ventilators and nebulizers to deliver medication directly to the lungs is likely to grow phenomenally between 2020 and 2021.
The following factors are likely to contribute to the growth of the nebulizer market during the forecast period:
- High Demand for Mesh Nebulizers
- COVID-19 Fueling Surge in Nebulizers
- Growing Popularity of Home Nebulization
- Favorable Patient Demographics
The study considers the present scenario of the nebulizer market and its market dynamics for the period 20192025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspect of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Insights by Geography
The North American market is growing at a moderate rate. Although the region is expected to grow at a slower rate than other regions, the COVID-19 pandemic has fueled a surge in nebulizers in the region, especially in the US. The country will witness a positive growth as national health spending is projected to grow at an average annual rate of 5.4% for 2019-2028, reaching $6.2 trillion by 2028. North America experienced a large-scale adoption of nebulizers over the past decade.
The rise in pollution rates, along with the growing number of cases related to respiratory troubles, even for neo-natal care, is one of the major reasons that has boosted the overall demand in North America. However, the COVID-19 pandemic situation has affected North America drastically. The number of people affected by COVID-19 is on the higher side; more than lakh people are affected by the coronavirus. A large number of people are admitted to emergency rooms and are on ventilators.
Insights by Vendors
The global nebulizer market share is fragmented with the presence of several global, regional, and local vendors offering a wide range of devices. OMRON, Koninklijke Philips, Drive DeVilbiss International, PARI, Feellife Health, Besco Medical, and Rossmax International, and Ca-Mi are the key market players dominating the market. Although the large vendors dominate, they are witnessing heavy competition from regional and local companies from India, China, Italy, and Germany. Many regional vendors also are offering cost-effective nebulizers in Europe, APAC, and the Middle East & Africa regions.
Prominent Vendors
- OMRON
- Business Overview
- Product Offerings
- Key Strengths
- Key Strategies
- Key Opportunities
- Koninklijke Philips
- Drive Devilbiss Healthcare
- Besco Medical
- PARI
- Rossmax International
- Feellife Health
- CA-MI
Other Prominent Vendors
- Liquide Medical Systems
- Business Overview
- Product Offerings
- Allied Healthcare Products
- Andreas Fahl Medizintechnik-Vertrieb
- AME Group
- Babybelle
- Big Eagle
- Bremed
- Well Swiss
- DR TRUST
- DELBio
- EP S.p.A
- ELMASLAR GROUP
- Flexicare
- Fazzini
- Hnkar Ecza ve Medikal
- K-JUMP HEALTH
- Little Doctor International
- MED2000
- San-Up
- HELTMAN Medikal
- Jiangsu Dengguan Medical Treatment Instrument
- Medpack Swiss Group
- Microlife
- MTD Medical Technology and Devices
- Norditalia Group
- Promed Group
- Tai Yu International Manu
- Trimpeks
- Vega Technologies
- Wuhan W.E.O. Science & Technology Development
- Westmed
- Compass Health Brands
- Koo Medical Equipment
- NOUVAG
- Sunset Healthcare Solutions
- Morepen Laboratories
- Trudell Medical International
Key Questions Answered:
- What is the nebulizer market size and growth rate during the forecast period?
- How is the growth of healthcare infrastructure supporting the growth trend of the nebulizer market in the North America region?
- Which product/portability/end-user segment is generating the largest revenues for the market?
- What are the factors leading to the growth of regional vendors in the nebulizer market?
- What is the impact of the COVID-19 pandemic on the European nebulizer market?
Market Dynamics
Opportunities & Trends
- High Demand for Mesh Nebulizers
- COVID-19 Pandemic Fuelling Surge in Demand for Nebulizers
- Growing Popularity of Home Nebulization
- Increase in Demand for Nebulizers In Developing Countries
Growth Enablers
- Favorable Patient Demographics
- Vendors Increased Focus on Publishing Positive Clinical Evidence of Nebulizers
- Technological Advancements in Nebulizers
- Increase in Usage of Portable Nebulizers
Market Restraints
- Presence of Alternatives for Nebulizers
- Limitations Associated with Nebulizers
- Intense Competiton Coupled with Pricing Pressure
For more information about this report visit https://www.researchandmarkets.com/r/ct3znk
